Pharmacokinetics of voriconazole and cytochrome P450 2C19 genetic status

被引：132

作者：

Ikeda, Y ^{[1
]}

Umemura, K

Kondo, K

Sekiguchi, K

Nakashima, M

机构：

[1] Hamamatsu Univ Sch Med, Hamamatsu, Shizuoka 43131, Japan

[2] Pfizer Japan Inc, Tokyo, Japan

[3] Hamamatsu Inst Clin Pharmacol & Therapeut, Hamamatsu, Shizuoka, Japan

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 2004年 / 75卷 / 06期

关键词：

D O I：

10.1016/j.clpt.2004.02.002

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：587 / 588

页数：2

共 5 条

[1] METOPROLOL AND MEPHENYTOIN OXIDATION POLYMORPHISMS IN FAR EASTERN ORIENTAL SUBJECTS - JAPANESE VERSUS MAINLAND CHINESE [J].

HORAI, Y ;

NAKANO, M ;

ISHIZAKI, T ;

ISHIKAWA, K ;

ZHOU, HH ;

ZHOU, BJ ;

LIAO, CL ;

ZHANG, LM .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 46 (02) :198-207

[2] Identification of the cytochrome P450 enzymes involved in the N-oxidation of voriconazole [J].

Hyland, R ;

Jones, BC ;

Smith, DA .

DRUG METABOLISM AND DISPOSITION, 2003, 31 (05) :540-547

[3] Genotyping of S-mephenytoin 4'-hydroxylation in an extended Japanese population [J].

Kubota, T ;

Chiba, K ;

Ishizaki, T .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1996, 60 (06) :661-666

[4] INTERETHNIC DIFFERENCES IN GENETIC-POLYMORPHISM OF DEBRISOQUIN AND MEPHENYTOIN HYDROXYLATION BETWEEN JAPANESE AND CAUCASIAN POPULATIONS [J].

NAKAMURA, K ;

GOTO, F ;

RAY, WA ;

MCALLISTER, CB ;

JACQZ, E ;

WILKINSON, GR ;

BRANCH, RA .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 38 (04) :402-408

[5] Effect of voriconazole on the pharmacokinetics of cyclosporine in renal transplant patients [J].

Romero, AJ ;

Le Pogamp, P ;

Nilsson, LG ;

Wood, N .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (04) :226-234

← 1 →